SCHEDULE 13G - FORBES

Company

Eloxx Pharmaceuticals, Inc.

Filed

February 17, 2004

Accession Number

0000903100-04-000072

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →